Relmada Therapeutics, Inc. RLMD
3.77 USD -0.40 (-9.59%)
At closeNov 5, 2026, 4:01 PM EST
3.77 0.00 0.00%
After hours · Nov 5, 4:01 PM ET
3.69 Day range 4.28
2.42 52-week range 8.00
- YTD
- -21.95%
- 1 year
- +50.20%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -59.10M | -83.89M | -103.70M | -161.25M | -125.70M | |
| -57.39M | -79.98M | -98.79M | -157.04M | -125.75M | |
| -1.45 | -2.65 | -3.28 | -5.30 | -7.16 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.50M | 3.86M | 4.09M | 5.40M | 44.44M | |
| 94.00M | 45.82M | 97.55M | 152.91M | 223.33M | |
| 7.49M | 10.30M | 12.19M | 12.47M | 15.06M | |
| 86.51M | 35.52M | 85.36M | 140.44M | 208.26M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -45.79M | -51.76M | -51.66M | -103.80M | -91.87M | |
| -48.14M | 51.56M | 50.45M | 19.73M | -54.12M | |
| 93.56M | -40.34K | -98.46K | 45.02M | 187.94M | |
| -360.49K | -234.54K | -1.30M | -39.05M | 41.95M |
